VCIM
STRO icon

Velan Capital Investment Management’s Sutro Biopharma STRO Stock Holding History

Velan Capital Investment Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8M Buy
512,160
+200,160
+64% +$3.62M 7.99% 3
2025
Q4 		$3.61M Hold
312,000
– – 2.09% 16
2025
Q3 		$2.71M Buy
312,000
+6,000
+2% +$51.1K 2.54% 14
2025
Q2 		$2.18M Buy
306,000
+203,000
+197% +$1.66M 2.16% 15
2025
Q1 		$670K Buy
103,000
+100,000
+3,333% +$1.57M 0.69% 24
2024
Q4 		$55.2K Buy
+3,000
New +$91.6K 0.05% 36

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Velan Capital Investment Management's STRO Position: Q1 2026 in Review

Velan Capital Investment Management increased its Sutro Biopharma (STRO) stake by 64% in Q1 2026, buying an estimated $3.62M and bringing the position to 512,160 shares worth $12.8M. The position accounts for 7.99% of the portfolio, ranked #3.

Velan Capital Investment Management first reported a position in STRO in Q4 2024 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Velan Capital Investment Management held 512,160 shares of Sutro Biopharma worth $12.8M as of Q1 2026.
  • Velan Capital Investment Management bought 200,160 Sutro Biopharma shares in Q1 2026, an estimated $3.62M.
  • Sutro Biopharma made up 7.99% of Velan Capital Investment Management's portfolio in Q1 2026, its #3 holding.
  • Velan Capital Investment Management first reported a position in Sutro Biopharma in Q4 2024 and has held it in 6 quarters since.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.